Literature DB >> 2495547

Report of the New England Task Force on Reducing Heart Disease and Stroke Risk.

S Havas1, S Wozenski, R Deprez, L Miller, R Charman, M Hamrell, L Green, S Benn.   

Abstract

Five years ago, a task force on reducing risk for heart disease and stroke was established by the six New England States. The task force included representatives from State public health departments, academia, the corporate sector, and voluntary organizations. This article is the final report of the task force. Heart disease and cerebrovascular disease are major causes of mortality in the New England region. Heart disease causes nearly 40 percent of all deaths in each of the six States and cerebrovascular disease, 7 percent of the deaths. Major risk factors for ischemic heart disease that have been identified--elevated serum cholesterol, high blood pressure, and cigarette smoking--are caused largely by lifestyle behaviors. Similarly, cerebrovascular disease results largely from uncontrolled high blood pressure, much of which is attributable to unhealthy lifestyle behaviors. In a series of studies evidence has accumulated that the reduction or elimination of these risk factors results in a decline in mortality rates. Many intervention programs have been mounted in the region, but there has been no population-wide effort to attack these risk factors. The task force proposed a broad range of activities for New Englanders at sites in the community and in health facilities. These activities would promote not smoking, exercising regularly, and maintaining desirable levels of serum cholesterol and blood pressure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495547      PMCID: PMC1580020     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  18 in total

1.  Leisure-time physical activity levels and risk of coronary heart disease and death. The Multiple Risk Factor Intervention Trial.

Authors:  A S Leon; J Connett; D R Jacobs; R Rauramaa
Journal:  JAMA       Date:  1987-11-06       Impact factor: 56.272

2.  Incidence and prediction of ischaemic heart-disease in London busmen.

Authors:  J N Morris; A Kagan; D C Pattison; M J Gardner
Journal:  Lancet       Date:  1966-09-10       Impact factor: 79.321

3.  Relation of weight change to changes in atherogenic traits: the Framingham Study.

Authors:  F W Ashley; W B Kannel
Journal:  J Chronic Dis       Date:  1974-03

4.  Current status of coronary prevention. Lessons from the Framingham study.

Authors:  T R Dawber; W B Kannel
Journal:  Prev Med       Date:  1972-12       Impact factor: 4.018

5.  Reducing the health consequences of smoking--a progress report.

Authors:  J Luoto
Journal:  Public Health Rep       Date:  1983 Jan-Feb       Impact factor: 2.792

6.  Public beliefs about causes and prevention of heart attacks.

Authors:  R B Shekelle; S C Liu
Journal:  JAMA       Date:  1978-08-25       Impact factor: 56.272

7.  Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project).

Authors:  P Puska; J T Salonen; A Nissinen; J Tuomilehto; E Vartiainen; H Korhonen; A Tanskanen; P Rönnqvist; K Koskela; J Huttunen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-17

Review 8.  High sodium-low potassium environment and hypertension.

Authors:  G R Meneely; H D Battarbee
Journal:  Am J Cardiol       Date:  1976-11-23       Impact factor: 2.778

9.  Physical activity and incidence of hypertension in college alumni.

Authors:  R S Paffenbarger; A L Wing; R T Hyde; D L Jung
Journal:  Am J Epidemiol       Date:  1983-03       Impact factor: 4.897

10.  Alcohol consumption and blood pressure. Kaiser-Permanente Multiphasic Health Examination data.

Authors:  A L Klatsky; G D Friedman; A B Siegelaub; M J Gérard
Journal:  N Engl J Med       Date:  1977-05-26       Impact factor: 91.245

View more
  1 in total

Review 1.  Emerging mechanistic targets in lung injury induced by combustion-generated particles.

Authors:  Marc W Fariss; M Ian Gilmour; Christopher A Reilly; Wolfgang Liedtke; Andrew J Ghio
Journal:  Toxicol Sci       Date:  2013-01-14       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.